首页> 美国卫生研究院文献>Molecules >The Novel 45-e13Diazepine-48-dione and Acyclic Carbamoyl Imino-Ureido Derivatives of Imidazole: Synthesis Anti-Viral and Anti-Tumor Activity Evaluations
【2h】

The Novel 45-e13Diazepine-48-dione and Acyclic Carbamoyl Imino-Ureido Derivatives of Imidazole: Synthesis Anti-Viral and Anti-Tumor Activity Evaluations

机译:新型45-e 13二氮杂-48-​​二酮和咪唑的无环氨基甲酰基氨基-脲基衍生物:合成抗病毒和抗肿瘤活性的评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the present paper, we report on the synthesis, and in vitro antiviral and cytostatic activities of a series of novel imidazole[4,5-e][1,3]diazepine-4,8-dione (compounds >9–>11) and acyclic carbamoyl imino-ureido imidazole (compounds >12 and >13) derivatives. These new type of chemical entities showed no significant activity on the broad spectrum of DNA and RNA viruses. Results of antiproliferative assays performed on a panel of selected human tumor cell lines revealed that only compounds >1 and >5 showed moderate and selective cytostatic effect against HeLa cells (IC50 = 24 and 32 µM) with no concomitant cytotoxic effects on human normal fibroblasts (BJ). Importantly, an imidazole derivative containing a pyrrolidine moiety linked via an ethylenic spacer (>3) showed a selective cytostatic effect toward cervical carcinoma (HeLa) cells (IC50 = 9.5 µM) with no apparent cytotoxicity on human normal fibroblasts (BJ). This compound can be therefore considered as a potential anti-tumor lead compound for further synthetic structure optimization.
机译:在本文中,我们报告了一系列新型咪唑[4,5-e] [1,3]二氮杂-4,8-​​二酮(化合物> 9 < / strong> – > 11 )和无环氨基甲酰基亚氨基-脲基咪唑(化合物> 12 和> 13 )衍生物。这些新型的化学实体在广泛的DNA和RNA病毒中没有表现出明显的活性。在一组选定的人类肿瘤细胞系上进行的抗增殖试验结果表明,只有化合物> 1 和> 5 对HeLa细胞显示出中度和选择性的细胞抑制作用(IC50 = 24和32 (μM)对人正常的成纤维细胞(BJ)没有伴随的细胞毒性作用。重要的是,含有通过亚乙基间隔子(> 3 )连接的吡咯烷部分的咪唑衍生物对宫颈癌(HeLa)细胞(IC50 = 9.5 µM)具有选择性抑制细胞生长的作用,而对人正常成纤维细胞没有明显的细胞毒性(BJ)。因此,该化合物可以被认为是用于进一步合成结构优化的潜在抗肿瘤先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号